Top

Published in:

01-06-2011 | Clinical Brief

Idiopathic Myelofibrosis in an Infant

Authors: Rupali R. Bavikar, Rajesh K. Kulkarni, Ashok D. Rathod, Meenal S. Hastak

Published in: Indian Journal of Pediatrics | Issue 6/2011

Abstract

Idiopathic Myelofibrosis (MF) is an extremely rare condition in children. It has a very variable clinical spectrum. Cases of secondary myelofibrosis associated with Vitamin D deficiency and Systemic Lupus Erythematosus have been reported from India .In this case report, the authors describe clinical signs, laboratory findings and histologic features in a 6 month old infant with Idiopathic myelofibrosis.

Johnston J Martin. Myelofibrosis. Available from URL: http://www.emedicine.medscape.com/article/956806-overview. Accessed May 15 2009.

Naithani R, Tyagi S, Choudhry VP. Secondary myelofibrosis in children. J Pediatr Hematol Oncol. 2008;30:196–8.PubMedCrossRef

Chandra J, Narayan S, Kumar P, et al. Myelofibrosis. Indian Pediatr. 1992;29:911–4.PubMed

Rani S, Maheshwari C, Singh T. Beohar PC.Idiopathic myelofibrosis. Indian Pediatr. 1984;21:817–20.PubMed

Narayan S, Chandra J, Sharma S, Aiyer H. Idiopathic Myelofibrosis in children. Indian JHemat and Blood Trans. 2000;18:100–1.

Bain BJ,Clark DM,Lampert IA,Wilkins BS. Myeloproliferative disorders.In Bain BJ,Clark DM,Lampert IA,Wilkins BS eds.Bone Marrow athology.Oxford,Blackwell Science,2000;202–208

Komura E, Tonetti C, Penard-Lacronique V. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res. 2005;65:3281–9.PubMed

Stephan JL, Galambrun C, Dutour A. Myelofibrosis: an unusual presentation of vitamin D-deficient rickets. Eur J Pediatr. 1999;158:828–9.PubMedCrossRef

Wolf BC, Neiman RS. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood. 1985;65:803–9.PubMed

10.

Agarwal BR, Bhalla K, Dalvi R, Currimbhoy ZE, Mehta KP. Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr. 1995;32:1207–10.PubMed

11.

Kerbauy DM, Gooley TA, Sale GE. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant. 2007;13:355–65.PubMedCrossRef

12.

Hasselbalch HC, Bjerrum OW, Jensen BA, et al. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. Am J Hematol. 2003;74:238–42.PubMedCrossRef

13.

Mesa RA, Nagorney DS, Schwager S. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic. Cancer. 2006;107:361–70.PubMedCrossRef

Title: Idiopathic Myelofibrosis in an Infant
Authors: Rupali R. Bavikar
Rajesh K. Kulkarni
Ashok D. Rathod
Meenal S. Hastak
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Indian Journal of Pediatrics / Issue 6/2011
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI: https://doi.org/10.1007/s12098-010-0340-6

At a glance: The STEP trials

Springer Medicine

Idiopathic Myelofibrosis in an Infant

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Intraarticular Heterotopic Ossification as the Initial Manifestation in a Child with Pseudohypoparathyroidism 1a

Interview with Parents of Children with Down Syndrome: Their Perceptions and Feelings

Gorham-Stout Syndrome with Chylothorax in a Six-Year-Old Boy

Hyperbilirubinemia and Intermittent Lower Urinary Tract Dysfunction

Status of Iodine Content of Salt in Four Regions of India

Splenic Lesions in Visceral Leishmaniasis